NUMI:CC News and Press, Numinus Wellness Inc. From 11/23/22

Psychoactive medicine has come a long way in the last couple of years and is not slowing down anytime soon. Gone are the days when hallucinogens conjured up images of tie-dye T-shirts and peace signs. The psychoactive renaissance taking place right now is fueled by governments, science, c...

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, December 8, 2022 Canada NewsWire VANCOUVER, BC , Nov. 22, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health car...

Numinus to Host Q4 and Year End 2022 Results Conference Call on November 29, 2022 PR Newswire VANCOUVER, BC , Nov. 15, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care compan...

Numinus Re-Launches "Psychedelic Therapy Frontiers" Podcast with additional hosts and topics Canada NewsWire Series is Devoted to Exploring The Psychedelic Renaissance and Cultivating a Healthy Mind, Body and Spirit VANCOUVER, BC , Nov. 1, 2022 ...

Numinus to Participate in Wonderland: Miami on November 3-5, 2022 Canada NewsWire VANCOUVER, BC , Oct. 31, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treat...

Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness Canada NewsWire Clinical program broadens access to ketamine-assisted therapy for an underserved population VANCOUVER, BC , Oct. 28, 2022 /CNW/ - Numinus Welln...

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022 Canada NewsWire VANCOUVER, BC , Oct. 7, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care ...

A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll clinical study using the Company’s unique psychedelic molecul...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 –  A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same transformational effec...

Numinus Develops Mushroom Tea for Use in Psychedelic Research Canada NewsWire Psilocybin-containing tea bag offers substitute for whole mushrooms and other solid therapeutics VANCOUVER, B.C , Oct. 5, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus"...